Table 2. Demographic and clinical characteristics of the patients after 24 weeks of the study.
| Characteristic | α-Lipoic acid | Placebo | P value |
|---|---|---|---|
| No. of patients | 41 | 34 | - |
| Sex, male/female | 24/17 | 18/16 | - |
| Age, yr | 63.76±7.84 | 62.09±9.43 | 0.405 |
| BMI, kg/m2 | 25.17±3.17 | 25.84±2.75 | 0.512 |
| HbA1c, % | 7.64±1.02 | 7.65±1.04 | 0.262 |
| SBP, mm Hg | 120.70±12.84 | 123.71±15.06 | 0.307 |
| DBP, mm Hg | 78.02±10.14 | 76.78±10.69 | 0.570 |
| Mean HR, beat/min | 74.30±9.58 | 73.71±9.72 | 0.770 |
| Lipid profiles, mg/dL | |||
| Total cholesterol | 161.23±32.49 | 164.32±41.55 | 0.685 |
| Triglyceride | 146.46±86.74 | 141.64±82.47 | 0.314 |
| HDL-C | 48.48±11.47 | 46.41±10.24 | 0.218 |
| LDL-C | 82.43±34.82 | 88.41±36.48 | 0.642 |
Values are presented as mean±standard deviation.
BMI, body mass index; HbA1c, glycosylated hemoglobin; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol.